Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Affected by Hepatocellular Carcinoma”

7 trials

Showing 7 of 7 results

Not applicableUnknownNCT01236989
What this trial is testing

Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC

Who this might be right for
Patients Affected by Hepatocellular CarcinomaDisease-Free SurvivalOverall Survival
University of Milan 120
Testing effectiveness (Phase 2)Ended earlyNCT01911273
What this trial is testing

Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Pfizer 3
Not applicableStudy completedNCT04553458
What this trial is testing

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sohag University 407
Not applicableUnknownNCT05987514
What this trial is testing

Multimodal Ultrasound and Hepatocellular Response to Local Treatments

Who this might be right for
Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Not applicableStudy completedNCT02977754
What this trial is testing

18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib

Who this might be right for
HCC
Istituto Clinico Humanitas 13
Not applicableStudy completedNCT02519075
What this trial is testing

11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE

Who this might be right for
Hepatocarcinoma
Istituto Clinico Humanitas 14
Testing effectiveness (Phase 2)Study completedNCT00484211
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AGC Biologics S.p.A. 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation